Hoth Therapeutics Inc (HOTH)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2023 | 12-2022 | 09-2022 | 06-2022 | 03-2022 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -2,184 | -11,372 | -7,893 | -5,249 | -2,572 |
| Accounts payable and accrued liabilities | -47 | 591 | 245 | -39 | -53 |
| Other Working Capital | -144 | 595 | 140 | -140 | -146 |
| Other Operating Activity | 85 | 889 | 760 | 1,069 | 633 |
| Operating Cash Flow | $-2,289 | $-9,298 | $-6,748 | $-4,359 | $-2,137 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | N/A | 1,236 | 1,236 | 1,236 | N/A |
| Other Investing Activity | 0 | -74 | -67 | -77 | -25 |
| Investing Cash Flow | $N/A | $1,162 | $1,169 | $1,159 | $-25 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 8,911 | 5,985 | 5,985 | 5,985 | N/A |
| Other Financing Activity | 0 | 51 | 0 | 0 | 0 |
| Financing Cash Flow | $8,911 | $6,036 | $5,985 | $5,985 | $N/A |
| Exchange Rate Effect | -6 | -10 | -10 | -6 | 4 |
| Beginning Cash Position | 6,429 | 8,538 | 8,538 | 8,538 | 8,538 |
| End Cash Position | 13,044 | 6,429 | 8,935 | 11,318 | 6,381 |
| Net Cash Flow | $6,616 | $-2,100 | $407 | $2,785 | $-2,162 |
| Free Cash Flow | |||||
| Operating Cash Flow | -2,289 | -9,298 | -6,748 | -4,359 | -2,137 |
| Free Cash Flow | -2,289 | -9,298 | -6,748 | -4,359 | -2,137 |